#GoldenCross $NVIV at 7.12 R2854 HiLo 7% T1Y 1 none fwdPE -0.3 DIV N/A #InVivo The #stocks #trading #finance #market

2020-02-15
29 Views

Golden Cross detected for NVIV (InVivo Therapeutics) at the close price of 7.12. Trading at a 7 % level between the 52week High (52.20) and 52week Low (3.60). The average analyst 1-year target price is 1.0 with an average none and a score of 0.0.

Golden Cross
2854 %
NVIV
7.12
InVivo Therapeutics
HiLo
7.2 %
Support
0.20
Resistance
8.10
50DMA
0.66
200DMA
0.66
52week high
52.20
52week low
3.60
10DMA
2.40
20DMA
1.34
100 Mean
0.54
Volume
159230
AvgDayVol
50174
MarketCap
3465617
EBITDA
-11708000
Revenue
0
PE
0.00
P2S
0.00
P2B
0.00
Dividend
0.00
Div Ex-Date

Further research links:

Marketwatch Yahoo Finance Google Finance StockTwits

You may be interested

HILO Index -671 Current 36.15 MA20 -39.29 Lower 271.09 Upper Bound #stocks #trading #markets #finance
Bull, Global Indicators
5 views
Bull, Global Indicators
5 views

HILO Index -671 Current 36.15 MA20 -39.29 Lower 271.09 Upper Bound #stocks #trading #markets #finance

Andreas Aigner - 2020-02-29

[Bullish] HILO Index -671 Current 36.15 MA20 -39.29 Lower 271.09 Upper Bound #stocks #trading #markets #finance x

Demark B/S Index 1.21 Avg 28.32 Std 121 Curr #stocks #trading #markets #finance
Bear, Global Indicators
6 views
Bear, Global Indicators
6 views

Demark B/S Index 1.21 Avg 28.32 Std 121 Curr #stocks #trading #markets #finance

Andreas Aigner - 2020-02-29

Demark B/S Index 1.21 Avg 28.32 Std 121 Curr #stocks #trading #markets #finance

50/200 DMA Index 1.94 Avg 5.26 Std -13 Curr #stocks #trading #markets #finance
Bull, Global Indicators
4 views
Bull, Global Indicators
4 views

50/200 DMA Index 1.94 Avg 5.26 Std -13 Curr #stocks #trading #markets #finance

Andreas Aigner - 2020-02-29

[Bullish] 50/200 DMA Index 1.94 Avg 5.26 Std -13 Curr #stocks #trading #markets #finance x

Leave a Comment

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

We use Cookies to improve our Site. Your are agreeing to this by continuing to use our Site.